All those who wish to attend the SOHO Highlights virtual meeting must register on this website. Live sessions were held on Wednesday, October 28th. The SOHO Highlights Virtual Environment, with on-demand content from the live meeting, will remain open through 11:59PM on November 28, 2020 (CDT, UTC/GMT -5). On-Demand Webinar Content is in process and will be posted by mid-day, Friday, October 30th. Delegates may access the virtual meeting at https://soho.click/HL after registering on this site.

SOHO Highlights: State of the Art and Next Questions

Sagar Lonial, MD, FACP
President, SOHO and Meeting Co-Chair

Hagop Kantarjian, MD
Secretary, SOHO and Meeting Co-Chair

More than 2,500 hematologic oncology specialists from 110 countries participated in the virtual Eighth Annual Meeting of the Society (SOHO 2020) in September. Approximately 170 topics were presented during the 3.5 day meeting from over 100 of the top investigators in the field. Based on popular demand, the Society of Hematologic Oncology (SOHO) will host a one-day program entitled, “SOHO Highlights: State of the Art and Next Questions” on October 28, 2020. The program will highlight the most important data presented at SOHO 2020 [State of the Art] as well as discuss what to expect in the near-term [Next Questions]. 

The “SOHO Highlights” meeting is designed to provide participants with an overview of the latest advances in hematologic malignancies and a preview of where the field is going next. Investigators from around the world will join the meeting for a day of learning and interactive, virtual discussion with the speakers. Each presentation is 25 minutes followed by a 10-minute, live Questions & Answer session with the audience. Note that the Zoom platform will be utilized to facilitate interaction with attendees.

SOHO Highlights Scientific Program

Wednesday, October 28, 2020  |  Virtual Event Venue

Time (UTC -5)*

Topic

Speaker

Affiliation

8:00 AM

Welcome & Introduction

Sagar Lonial, MD, FACP

President & Chair, SOHO

8:10 AM

State of the Art & Next Questions: Acute Lymphoblastic Leukemia

Hagop Kantarjian, MD

The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

8:35 AM

Audience Q & A

 

 

8:45 AM

State of the Art & Next Questions: Acute Myeloid Leukemia

Amer Zeidan, MBBS

Yale Cancer Center, New Haven, Connecticut, USA

9:10 AM

Audience Q & A

 

 

9:20 AM

State of the Art & Next Questions: Cellular Therapy

Sergio Giralt, MD

Memorial Sloan Kettering Cancer Center, New York, New York, USA

9:45 AM

Audience Q & A

 

 

9:55 AM

State of the Art & Next Questions: Chronic Lymphocytic Leukemia

Jennifer R. Brown, MD, PhD

Dana-Farber Cancer Institute, Boston, Massachusetts, USA

10:20 AM

Audience Q & A

 

 

10:30 AM

Break

 

 

10:45 AM

State of the Art & Next Questions: Chronic Myeloid Leukemia

Michael Deininger, MD, PhD

Huntsman Cancer Hospital, University of Utah, Salt Lake City, Utah, USA

11:10 AM

Audience Q & A

 

 

11:20 AM

State of the Art & Next Questions: Aggressive B-Cell Lymphoma

Sandeep S. Dave, MD, MS

Duke University School of Medicine, Durham, North Carolina, USA

11:45 AM

Audience Q & A

 

 

11:55 AM

State of the Art & Next Questions: Indolent B-Cell Lymphoma

Robert Marcus, MA, FRCP, FRCPath

Leaders in Oncology Care, London, United Kingdom

12:20 PM

Audience Q & A

 

 

12:30 PM

State of the Art & Next Questions: T-Cell Lymphoma

Kerry Savage, MD

BC Cancer Agency, Vancouver, British Columbia, Canada

12:55 AM

Audience Q & A

 

 

1:05 PM

Break

 

 

1:35 PM

State of the Art & Next Questions: Mantle Cell Lymphoma

Jonathon B. Cohen, MD, MS

Emory University School of Medicine, Atlanta, Georgia, USA

2:00 PM

Audience Q & A

 

 

2:10 PM

State of the Art & Next Questions:Hodgkin Lymphoma

David J. Straus, MD

Memorial Sloan Kettering Cancer Center, New York, New York, USA

2:35 PM

Audience Q & A

 

 

2:45 PM

State of the Art & Next Questions: Multiple Myeloma

Sagar Lonial, MD, FACP

Emory University School of Medicine, Atlanta, Georgia, USA

3:10 PM

Audience Q & A

 

 

3:20 PM

State of the Art & Next Questions: Myelodysplastic Syndromes

Guillermo Garcia-Manero, MD

The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

3:45 PM

Audience Q & A

 

 

3:55 PM

State of the Art & Next Questions: Myeloproliferative Neoplasms

Srdan Verstovsek, MD, PhD

The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

4:20 PM

Audience Q & A

 

 

4:30 PM

Closing Remarks

Sagar Lonial, MD, FACP

President & Chair, SOHO

4:35 PM

Adjourn

 

 

*All times are listed in Central Daylight Time (CDT) which is 5 hours behind Coordinated Universal Time (UTC -5).